| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Department of Pharmacy, Center of Drug Research,
2 Department of Medicine II, Klinikum Grosshadern, and
3 Department of Biology I, University of Munich, Munich, Germany, and
4 Cancer Research Institute, Arizona State University, Tempe, Arizona
Cephalostatin 1 is a bis-steroidal marine natural product with a unique cytotoxicity profile in the in vitro screen system of the National Cancer Institute, suggesting that it may affect novel molecular target(s). Here we show that cephalostatin 1 induces a novel pathway of receptor-independent apoptosis that selectively uses Smac/DIABLO (second mitochondria-derived activator of caspases/direct inhibitor of apoptosis-binding protein with a low isoelectric point) as a mitochondrial signaling molecule. At nanomolar concentrations, cephalostatin 1 triggers dose- and time-dependent DNA fragmentation in leukemia Jurkat T cells. Apoptosis was found to be dependent on caspase activity because the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone blocks cephalostatin 1-mediated DNA fragmentation. The CD95 death receptor as well as other caspase-8-requiring death receptors were not involved because Jurkat T cells lacking the CD95 receptor or caspase-8 and control cells responded equally to cephalostatin 1. Although cephalostatin 1 affects mitochondria by dissipating the mitochondrial membrane potential, neither cytochrome c nor apoptosis-inducing factor is released, as shown by Western blot analysis. Interestingly, cephalostatin 1 selectively triggers the mitochondrial release of the inhibitor of apoptosis antagonist Smac/DIABLO. Overexpression of the antiapoptotic protein Bcl-xL delayed both Smac/DIABLO release and onset of apoptosis, suggesting that Smac/DIABLO is required for cephalostatin 1-induced apoptosis. This new mitochondrial pathway is accompanied by marked structural changes of mitochondria as shown by transmission electron microscopy.
This article has been cited by other articles:
![]() |
U. M. Schneiders, L. Schyschka, A. Rudy, and A. M. Vollmar BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells Mol. Cancer Ther., October 1, 2009; 8(10): 2914 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lopez-Anton, A. Rudy, N. Barth, L. M. Schmitz, G. R. Pettit, K. Schulze-Osthoff, V. M. Dirsch, and A. M. Vollmar The Marine Product Cephalostatin 1 Activates an Endoplasmic Reticulum Stress-specific and Apoptosome-independent Apoptotic Signaling Pathway J. Biol. Chem., November 3, 2006; 281(44): 33078 - 33086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mohan, A. A. Gandhi, B. C. Bhavya, R. Rashmi, D. Karunagaran, R. Indu, and T. R. Santhoshkumar Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol J. Biol. Chem., June 30, 2006; 281(26): 17599 - 17611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Blumenthal, A. K. Kiemer, G. Tiegs, S. Seyfried, M. Holtje, B. Brandt, H.-D. Holtje, S. Zahler, and A. M. Vollmar Metalloporphyrins inactivate caspase-3 and -8 FASEB J, August 1, 2005; 19(10): 1272 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Muller, V. M. Dirsch, A. Rudy, N. Lopez-Anton, G. R. Pettit, and A. M. Vollmar Cephalostatin 1 Inactivates Bcl-2 by Hyperphosphorylation Independent of M-Phase Arrest and DNA Damage Mol. Pharmacol., May 1, 2005; 67(5): 1684 - 1689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |